Monte Rosa Therapeutics, Inc. (GLUE)
9.31
-1.00
(-9.70%)
USD |
NASDAQ |
Nov 12, 16:00
9.50
+0.19
(+2.04%)
After-Hours: 20:00
Monte Rosa Therapeutics Price : 9.31 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 10.17 | 10.28 | 9.28 | 9.31 | 1.246M |
| Nov 11, 2026 | 10.48 | 10.54 | 10.16 | 10.31 | 1.261M |
| Nov 10, 2026 | 10.42 | 10.85 | 10.40 | 10.50 | 1.506M |
| Nov 09, 2026 | 10.83 | 10.88 | 10.28 | 10.58 | 1.367M |
| Nov 06, 2026 | 10.30 | 10.67 | 9.88 | 10.57 | 1.006M |
| Nov 05, 2026 | 10.48 | 10.58 | 10.13 | 10.25 | 1.715M |
| Nov 04, 2026 | 10.65 | 11.08 | 10.07 | 10.82 | 1.962M |
| Nov 03, 2026 | 10.85 | 11.00 | 10.37 | 10.41 | 1.364M |
| Nov 02, 2026 | 10.79 | 11.02 | 10.43 | 10.63 | 1.767M |
| Oct 30, 2026 | 10.85 | 11.13 | 10.45 | 10.76 | 1.349M |
| Oct 29, 2026 | 11.00 | 11.20 | 10.73 | 10.87 | 1.307M |
| Oct 28, 2026 | 10.51 | 10.88 | 10.40 | 10.85 | 1.625M |
| Oct 27, 2026 | 10.47 | 10.71 | 10.34 | 10.66 | 1.458M |
| Oct 26, 2026 | 10.94 | 10.94 | 10.32 | 10.48 | 1.227M |
| Oct 23, 2026 | 11.03 | 11.03 | 10.61 | 10.84 | 817827.0 |
| Oct 22, 2026 | 11.14 | 11.39 | 11.00 | 11.11 | 1.285M |
| Oct 21, 2026 | 11.38 | 11.74 | 11.08 | 11.22 | 1.080M |
| Oct 20, 2026 | 10.72 | 11.42 | 10.56 | 11.36 | 1.866M |
| Oct 19, 2026 | 9.84 | 10.71 | 9.76 | 10.66 | 1.926M |
| Oct 16, 2026 | 10.18 | 10.23 | 9.705 | 9.74 | 885433.0 |
| Oct 15, 2026 | 9.95 | 10.24 | 9.88 | 10.12 | 1.544M |
| Oct 14, 2026 | 9.76 | 10.10 | 9.71 | 9.84 | 1.093M |
| Oct 13, 2026 | 10.45 | 10.54 | 9.852 | 9.89 | 2.714M |
| Oct 12, 2026 | 10.29 | 10.63 | 10.14 | 10.52 | 2.095M |
| Oct 09, 2026 | 10.36 | 10.52 | 10.21 | 10.30 | 1.202M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| United Therapeutics Corp. | 593.31 |
| ACADIA Pharmaceuticals, Inc. | 18.14 |
| Alnylam Pharmaceuticals, Inc. | 156.65 |
| Anika Therapeutics, Inc. | 13.81 |
| Savara, Inc. | 4.72 |
Price Related Metrics
| PS Ratio | 12.43 |
| Price to Book Value | 1.603 |
| Earnings Yield | -16.64% |
| Market Cap | 795.36M |